Analysts Estimate Veru Inc. (VERU) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 11/25/21
Veru Inc.: Women's Health, COVID Trial, Oncology Pipeline - 3 Opportunities For The Price Of 1Seeking Alpha • 11/24/21
Veru to Report Fiscal 2021 Fourth-Quarter, Full-Year Financial Results, Host Conference Call on December 2ndGlobeNewsWire • 11/18/21
Veru Ranked as one of the Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500GlobeNewsWire • 11/18/21
Veru to Participate in Fireside Chat at the Jefferies London Healthcare Conference on November 16-18, 2021GlobeNewsWire • 11/08/21
Veru Enrolls First Patient in International Phase 3 ARTEST Clinical Trial of Enobosarm in Metastatic Breast CancerGlobeNewsWire • 10/13/21
Veru Announces Positive Updated Data from Phase 1b/2 Sabizabulin Study in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 ESMO CongressGlobeNewsWire • 09/20/21
Veru, Inc. (VERU) CEO Mitchell Steiner on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/12/21
Veru Sets Another Quarterly Record in Both Net Revenues and in Gross Profit for Fiscal 2021 Third QuarterGlobeNewsWire • 08/12/21
Earnings Preview: Veru Inc. (VERU) Q3 Earnings Expected to DeclineZacks Investment Research • 08/05/21
Veru to Report Fiscal 2021 Third-Quarter Financial Results, Host Conference Call on August 12thGlobeNewsWire • 07/29/21
Veru Announces the Presentation of a Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in Men with Metastatic Castration Resistant Prostate Cancer at the 2021 European Association of Urology Annual CongressGlobeNewsWire • 06/28/21
Veru Enrolls First Patient in Phase 3 VERACITY Clinical Trial of Sabizabulin (VERU-111) in Metastatic Castration Resistant and Androgen Receptor Targeting Agent Resistant Prostate CancerGlobeNewsWire • 06/25/21
Veru Enrolls First Patient in Phase 2 Clinical Trial of VERU-100, Novel Long-acting GnRH Antagonist Decapeptide Injection Formulation, for the Treatment of Hormone Sensitive Advanced Prostate CancerGlobeNewsWire • 06/10/21